Table III.
Comparison of clinical and laboratory characteristics of IgG-anti-TPO (+) and IgG-anti-TPO (−) CSU patients.
IgG-anti-TPO (+) CSU n=14 |
IgG-anti-TPO (−) CSU n=45 |
p | |
---|---|---|---|
Age (years)* | 46.5(23–67) | 40(18–65) | 0.075 |
Female, % | 85.7 | 73.3 | 0.48 |
Duration of disease, months* | 24(2–36) | 16(2–240) | 0.58 |
UAS-7* | 17.5(10–32) | 18(8–32) | 0.63 |
Total serum IgE IU/ml* | 123.3(12.5–385) | 78.6(2–1175) | 0.91 |
IgE-anti-TPO Abs* | 0.22(0.07–0.92) | 0.15(0.06–1.21) | 0.28 |
IgE-anti-TPO U/ml* | 2.22(0.72–9.23) | 1.5(0.65–12.1) | 0.31 |
CSU, chronic spontaneous urticaria; UAS-7, urticarial activity score for 7 consecutive days, TPO, thyroid peroxidase; Abs, Absorbance;
Data are expressed as median (min–max).